These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29057763)

  • 1. Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma.
    Sano R; Kanomata N; Suzuki S; Shimoya K; Sato Y; Moriya T; Shiota M
    Tohoku J Exp Med; 2017 Oct; 243(2):107-114. PubMed ID: 29057763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
    Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
    Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.
    Kanomata N; Sato Y; Miyaji Y; Nagai A; Moriya T
    J Clin Pathol; 2013 Jul; 66(7):613-9. PubMed ID: 23543668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of vasohibin-1 expression in patients with prostate cancer.
    Kosaka T; Miyazaki Y; Miyajima A; Mikami S; Hayashi Y; Tanaka N; Nagata H; Kikuchi E; Nakagawa K; Okada Y; Sato Y; Oya M
    Br J Cancer; 2013 May; 108(10):2123-9. PubMed ID: 23591203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.
    Mikami S; Oya M; Kosaka T; Mizuno R; Miyazaki Y; Sato Y; Okada Y
    Lab Invest; 2017 Jul; 97(7):854-862. PubMed ID: 28287633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
    Torii C; Hida Y; Shindoh M; Akiyama K; Ohga N; Maishi N; Ohiro Y; Ono M; Totsuka Y; Kitagawa Y; Tei K; Sato Y; Hida K
    Anticancer Res; 2017 Mar; 37(3):1219-1225. PubMed ID: 28314285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.
    Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L
    Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
    Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
    Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
    Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
    Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma.
    Zhao G; Yang Y; Tang Y; Han R; Sun Y
    Med Oncol; 2012 Dec; 29(5):3325-34. PubMed ID: 22865127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
    El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
    Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
    Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
    Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Vasohibin-1 in Human Carotid Atherosclerotic Plaque.
    Fukumitsu R; Minami M; Yoshida K; Nagata M; Yasui M; Higuchi S; Fujikawa R; Ikedo T; Yamagata S; Sato Y; Arai H; Yokode M; Miyamoto S
    J Atheroscler Thromb; 2015; 22(9):942-8. PubMed ID: 25843115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of vasohibin-1 in esophageal carcinoma cells: Inhibition of cell growth and migration.
    Ma D; Li J; Wang J; Sun Z; Wang K
    Mol Med Rep; 2017 Aug; 16(2):1479-1485. PubMed ID: 29067450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
    Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
    Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is vasohibin-1 for more than angiogenesis inhibition?
    Sato Y
    J Biochem; 2011 Mar; 149(3):229-30. PubMed ID: 21217147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer.
    Kobayashi H; Kosaka T; Mikami S; Miyazaki Y; Matsumoto K; Kikuchi E; Miyajima A; Kameyama K; Sato Y; Oya M
    Oncotarget; 2018 Feb; 9(12):10203-10210. PubMed ID: 29535800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.